MedPath

HCNC

HCNC logo
🇧🇪Belgium
Ownership
Private, Subsidiary
Established
1977-01-01
Employees
1K
Market Cap
-
Website
http://www.uzbrussel.be

Corifollitropin Alfa Followed by hpHMG in a Long GnRH Agonist Protocol for the Treatment of Poor Ovarian Responders

Phase 2
Completed
Conditions
Infertility
Poor Ovarian Response
Interventions
Drug: Corifollitropin alfa 150μg
Drug: hpHMG
First Posted Date
2012-11-22
Last Posted Date
2013-05-09
Lead Sponsor
Universitair Ziekenhuis Brussel
Target Recruit Count
57
Registration Number
NCT01732094
Locations
🇧🇪

Centre for Reproductive Medicine UZ Brussel, Brussels, Belgium

Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol

Phase 2
Completed
Conditions
Infertility
Poor Ovarian Response
Interventions
First Posted Date
2012-11-22
Last Posted Date
2013-05-09
Lead Sponsor
Universitair Ziekenhuis Brussel
Target Recruit Count
51
Registration Number
NCT01732068
Locations
🇧🇪

Centre for Reproductive Medicine UZ Brussel, Brussels, Belgium

mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma

Phase 2
Completed
Conditions
Malignant Melanoma Stage IV
Malignant Melanoma Stage III
Interventions
Biological: Dendritic cell therapy
First Posted Date
2012-08-31
Last Posted Date
2017-05-24
Lead Sponsor
Universitair Ziekenhuis Brussel
Target Recruit Count
88
Registration Number
NCT01676779
Locations
🇧🇪

UZ Brussel, Brussel, Belgium

D2 Versus D4 Corifollitropin Alfa in GnRH Antagonists

Phase 4
Completed
Conditions
Infertility
Interventions
First Posted Date
2012-07-04
Last Posted Date
2014-12-03
Lead Sponsor
Universitair Ziekenhuis Brussel
Target Recruit Count
67
Registration Number
NCT01633580
Locations
🇧🇪

UZ Brussel, Jette, Belgium

Timing of Intrauterine Insemination (IUI) 24 or 48 Hours After Spontaneous Luteinizing Hormone (LH) Peak

Phase 4
Completed
Conditions
Pregnancy
Interventions
Procedure: intra-uterine insemination
First Posted Date
2012-06-18
Last Posted Date
2019-04-19
Lead Sponsor
Universitair Ziekenhuis Brussel
Target Recruit Count
435
Registration Number
NCT01622023
Locations
🇧🇪

Christophe Blockeel, Brussel, Belgium

HCG Versus Spontaneous LH in Intrauterine Insemination (IUI ) Cycles

Early Phase 1
Completed
Conditions
Spontaneous Triggering of Ovulation vs. Administration of Human Chorionic Gonadotropin in Patients Undergoing IUI
Interventions
First Posted Date
2011-08-11
Last Posted Date
2011-08-11
Lead Sponsor
Universitair Ziekenhuis Brussel
Target Recruit Count
300
Registration Number
NCT01414673
Locations
🇧🇪

Uzbrussel, Brussel, Laarbeeklaan 101, Belgium

Earlier Triggering in Rec-FSH/GnRH Antagonist Cycles

Phase 2
Completed
Conditions
hCG
Interventions
Other: 16mm triggering
First Posted Date
2011-07-08
Last Posted Date
2011-08-04
Lead Sponsor
Universitair Ziekenhuis Brussel
Target Recruit Count
100
Registration Number
NCT01390207

Stop Menstruation and Pregnancy Rates in Antagonist Protocol

Completed
Conditions
Infertility
First Posted Date
2011-05-20
Last Posted Date
2011-05-20
Lead Sponsor
Universitair Ziekenhuis Brussel
Target Recruit Count
90
Registration Number
NCT01357473

Simultaneous Integrated Boost Preoperative Radiotherapy for Rectum Cancer

Phase 3
Completed
Conditions
Rectal Cancer
Interventions
Radiation: Radiotherapy with boost
Other: Chemoradiotherapy
First Posted Date
2010-10-20
Last Posted Date
2020-12-30
Lead Sponsor
Universitair Ziekenhuis Brussel
Target Recruit Count
156
Registration Number
NCT01224392
Locations
🇧🇪

UZ Brussel, Vrije Universiteit Brussel, dienst Radiotherapie, Jette, Belgium

🇧🇪

UZ Brussel , Vrije Universiteit Brussel, dienst Radiotherapie, Jette, Brussel, Belgium

Methylprednisolone Addition in IVF Treatment of Infertile Couples

Phase 4
Conditions
In Vitro Fertilization
Interventions
Other: In vitro fertilization treatment for infertility
First Posted Date
2010-10-14
Last Posted Date
2010-10-14
Lead Sponsor
Universitair Ziekenhuis Brussel
Target Recruit Count
130
Registration Number
NCT01220791
Locations
🇬🇷

Biogenesis, Thessaloniki, Pylaia, Greece

© Copyright 2025. All Rights Reserved by MedPath